N Ismail, B BECKER, P STRZELCZYK, E RITZ - Kidney international, 1999 - nature.com Renal disease and hypertension in non–insulin-dependent diabetes mellitus.
Recent epidemiologic data demonstrate a dramatic increase in the incidence of
end-stage renal disease (ESRD) in patients with non-insulin-dependent ... Cited by 181 - Related articles - BL Direct - All 4 versions
- ►asnjournals.org G Gambaro, I Kinalska, A Oksa, P Pont'uch, M … - Journal of the American Society of Nephrology, 2002 - Am Soc Nephrol ABSTRACT. Diabetic nephropathy may be effectively prevented and treated by
controlling glycemia and administering angiotensin-converting enzyme (ACE)
inhibitors. However, strict metabolic control can be difficult, and ACE ... Cited by 79 - Related articles - BL Direct - All 7 versions
- ►asnjournals.org M CEOL, G GAMBARO, U SAUER, B BAGGIO, … - Journal of the American Society of Nephrology, 2000 - Am Soc Nephrol Abstract. Chronic induction of the prosclerotic cytokine transforming growth
factor ß (TGF-ß) has been implicated in the pathogenesis of diabetic
nephropathy. In a rat model of diabetes mellitus-induced ... Cited by 38 - Related articles - BL Direct - All 5 versions
- ►asnjournals.org G Gambaro, FJ Van der Woude - Journal of the American Society of Nephrology, 2000 - Am Soc Nephrol Because diabetic nephropathy occurs in 20 to 40% of patients with diabetes
mellitus, it has become one of the most important causes of end-stage renal
disease. The latest incidence figures vary from 16% of patients starting ... Cited by 27 - Related articles - BL Direct - All 4 versions
- ►asnjournals.org [PDF] JW Van der Pijl, FJ Van der Woude, PH … - Journal of the American Society of Nephrology, 1997 - Am Soc Nephrol Page 1. Danaparoid Sodium Lowers Proteinuria in Diabetic Nephropathy JOHAN W. VAN
DER PIJL,* FOKKO J. VAN DER WOUDE,* PETRONELLA HLM GEELHOEDDUIJVESTIJN,t ... Cited by 27 - Related articles - BL Direct - All 9 versions
C Weigert, K Brodbeck, HU Häring, G … - Kidney international, 2001 - nature.com Hyperglycemia-induced overexpression of prosclerotic transforming growth factor-
1 (TGF- 1) has been implicated in the pathogenesis of diabetic nephropathy.
Since previous in vivo studies demonstrated a renoprotective effect of low- ... Cited by 25 - Related articles - BL Direct - All 4 versions
- ►fastbot.de [PDF] JW van der Pijl, FJ van der Woude, W Swart, … - The Lancet, 1997 - Elsevier In diabetes mellitus, both retinopathy and nephropathy represent specific
microvascular disease with increased capillary permeability resulting in hard
exudates, foveal oedema, and albuminuria. The decrease of heparan-sulphate ... Cited by 21 - Related articles - BL Direct - All 8 versions
S Nielsen, A Schmitz, T Bacher, M Rehling, J … - Diabetologia, 1999 - Springer Type II (non-insulin-dependent) diabetic patients with abnormal urinary albumin
excretion rate (UAE), even in the microalbuminuric range (UAE 20±200 mg/min),
have an increased prevalence of vas- cular disease and risk of ... Cited by 19 - Related articles - BL Direct - All 3 versions
- ►nih.gov [PDF] OE Ayodele, CO Alebiosu, BL Salako - Journal of the National Medical Association, 2004 - pubmedcentral.nih.gov The earliest clinical evidence of diabetic nephropathy is microalbuminuria.
Progression from microalbuminuria to overt nephropathy occurs in 20-40% within a
10-year perod with approximately 20% of these patients progressing to ... Cited by 19 - Related articles - BL Direct - All 4 versions
O Torffvit, B Rippe - Nephron, 1999 - content.karger.com Background: In diabetic nephropathy, a reduction in negative membrane charge in
the glomerular filter, ie, the number of sulphated groups of glycosaminoglycans,
has been argued to lead to increases in excretion of negatively charged ... Cited by 16 - Related articles - BL Direct - All 5 versions
